Business Overview
Beyond providing traditional IP legal services, we are dedicated to helping clients build systematic and forward-looking intellectual property protection and value realization systems. By deeply engaging in clients' R&D, commercialization, and capital operation processes, we offer integrated solutions encompassing IP risk assessment and early warning, strategic planning, transaction structure design, technology transfer support, and full-cycle rights enforcement management. In scenarios involving complex technology transactions, major infringement litigation, cross-border licensing, and IP financing, we leverage our interdisciplinary expertise to provide clients with high-level support that balances legal rigor with commercial viability.
Llinks operates multiple specialized and complementary IP teams, each with distinct characteristics. This structure allows us to flexibly allocate resources based on specific client needs, delivering customized, efficient, and high-value-added professional services. We consistently aim to help clients build core IP competitiveness and maximize the value of their technology assets.
Key Capabilities
Strategy and Portfolio Management
-
Intellectual Property Strategy
-
Intellectual Property Systems
-
Patent Mining
-
Patent Applications, Invalidation, and Design-around Strategies
-
Patent Monitoring and Industry Patent Research
-
Software Copyright Registration
-
Trademark Registration
Transactions and Commercialization
-
Freedom-to-Operate (FTO) Analysis
-
Intellectual Property Due Diligence
-
Technology Licensing, Acquisition, Transfer
-
Technology Contribution as Capital
-
Intellectual Property Asset-Backed Securitization (ABS)
-
Collaborative Development, "Industry-University-Research" Cooperation
Dispute Resolution
Practice Highlights
-
Represented Ant International (Singapore) and MTN Group (South Africa) in completing a cross-border licensing project for FinTech patents, trade secrets, and trademarks to their joint venture, Midas (United Arab Emirates)
-
Represented Allist Pharmaceuticals in the exclusive Greater China patent licensing and clinical trial data rights transfer project for KRAS G12C and SHP2 inhibitors
-
Represented Escugen and Yuyan Bio in completing the global co-development patent assignment and overseas rights sub-licensing project for a FIC-ADC drug
-
Represented Zhejiang Shenghe Network Technology Co., Ltd. in a declaratory dispute over copyright non-infringement against ChuanQi IP Co., Ltd., which was selected as one of the "Top Ten Typical Cases of Internet Intellectual Property Rights by the Hangzhou Internet Court"
-
Represented a smart glasses enterprise in successfully responding to and resolving a U.S. Section 337 investigation
-
Represented a client in winning a groundbreaking ruling rendered by the Supreme People's Court in a patent ownership dispute
Market Recognition
Industry Insights
-
At Long Last: China's New Drug Data Exclusivity Regime
Download -
Technology Transfers in response to US Export Controls --- a Discussion from US Restrictions on Selling EDA to China
Download -
A Class Action Over the “Apple Tax” and Its Implications for Chinese Developers
Download -
Legal Implications of General AI Agents: The Case of Manus
Download -
DeepSeek Facing Legal Challenges in Overseas Market
Download -
Data Intellectual Property Protection and Registration Practice
Download